Regulatory and Legal Compliance Failures: Cencora operates in a highly regulated industry and any failure to comply with complex federal, state, and international laws and regulations, including those related to controlled substances, healthcare fraud, and anti-bribery, could result in significant fines, sanctions, license revocations, or reputational damage.

Supply Chain Disruptions and Product Shortages: The company's ability to distribute pharmaceuticals relies heavily on the consistent supply from manufacturers. Disruptions due to natural disasters, geopolitical events, manufacturing issues, or increased demand could lead to drug shortages, impact Cencora's ability to serve its customers, and harm its financial performance.

Intense Competition and Pricing Pressures: Cencora faces significant competition from other large pharmaceutical distributors, smaller regional players, and direct sales channels from manufacturers. Intense pricing pressure from healthcare payers, government initiatives to reduce drug costs, and customers seeking lower prices could erode profit margins.